The Patent Finder

Onconova Therapeutics, Inc.

Also on record
Records under this name other than the patents Onconova Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.

Back to Onconova Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,576,050Methods and Compostions for Treatment of Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,156,856Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(CARBOXYMETHYL)AMINO]-4-Methoxybenzylsulphone with Enhanced Stability and Bioavailability
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,098,862Formulations with Enhanced Stability and Bioavailability for Administantion of (E)-2,6-Dialkoxystyryl 4-Substituted Benzylsulfones
Formerly held
Lapsed on the fee record
Ended Oct 16, 2026 · Low confidence
Lapsed on the fee recordEnded Oct 16, 2026Low confidence
US 11,382,877Formulation of (E)-2,4,6-Trimethoxystyryl-3-[(CARBOXYMETHYL)AMINO]-4-Methoxybenzylsulphone with Enhanced Stability and Bioavailability
Formerly held
Lapsed on the fee record
Ended Jul 12, 2026 · High confidence
Lapsed on the fee recordEnded Jul 12, 2026High confidence
US 8,735,620Processes for preparing (E)-styrylbenzylsulfone compounds and uses thereof for treating proliferative disorders
Lapsed on the fee record
Ended May 27, 2026 · USPTO record
Lapsed on the fee recordEnded May 27, 2026USPTO record
US 7,932,242Substituted Phenoxy-And Phenylthio-Derivatives for Treating Proliferative Disorders
Term ended
Ended no later than Mar 15, 2025 · Medium confidence
Term endedEnded no later than Mar 15, 2025Medium confidence
US 7,744,889Alpha, Beta-Unsaturated Sulfoxides for Treating Proliferative Disorders
Formerly held
Term ended
Term ended Jan 11, 2025 · High confidence
Term endedTerm ended Jan 11, 2025High confidence
US 8,324,190Treatment of Proliferative Disorders with Amino-Substituted (E)-2,6- Dialkoxystyryl 4-Substituted Benzylsulfones
Formerly held
Term ended
Ended no later than Jan 11, 2025 · Low confidence
Term endedEnded no later than Jan 11, 2025Low confidence
US 7,598,232Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders
Term ended
Term ended Dec 10, 2024 · USPTO record
Term endedTerm ended Dec 10, 2024USPTO record
US 6,646,009N-(ARYL)-2-Arylethenesulfonamides and Therapeutic Uses Thereof
Formerly held
Term ended
Term ended Feb 28, 2022 · High confidence
Term endedTerm ended Feb 28, 2022High confidence
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited